Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

APOLLO ENDOSURGERY, INC.

(APEN)
  Report
Delayed Nasdaq  -  04:00:00 2023-01-26 pm EST
9.850 USD    0.00%
01/23Cowen Downgrades Apollo Endosurgery to Market Perform From Outperform, Adjusts Price Target to $10 From $13
MT
01/05North American Morning Briefing: Futures Dip As a -2-
DJ
01/04Stifel Downgrades Apollo Endosurgery to Hold From Buy, Price Target is $10
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Easing Concerns Over China COVID-19 Protests Prompt Quiet Premarket Session for US Equities

11/29/2022 | 08:53am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
APOLLO ENDOSURGERY, INC. 0.00% 9.85 Delayed Quote.-1.20%
BOSTON SCIENTIFIC CORPORATION 0.50% 46.35 Delayed Quote.-0.32%
BRENT OIL 0.14% 87.58 Delayed Quote.0.61%
DAX 0.34% 15132.85 Delayed Quote.8.69%
DOW JONES INDUSTRIAL 0.61% 33949.41 Real-time Quote.1.80%
FTSE 100 0.21% 7761.11 Delayed Quote.3.93%
KALA PHARMACEUTICALS, INC. 20.98% 18.97 Delayed Quote.-50.28%
MSCI UNITED KINGDOM (STRD) 0.19% 1146.2 Real-time Quote.6.21%
NASDAQ COMPOSITE 1.76% 11512.41 Real-time Quote.8.09%
NIKKEI 225 -0.12% 27362.75 Real-time Quote.4.98%
S&P GSCI BRENT CRUDE INDEX 0.45% 746.2136 Real-time Quote.0.33%
S&P UNITED KINGDOM (PDS) 0.20% 1576.51 Real-time Quote.3.54%
S&P/CITIC 300 INDEX 0.59% 3823.29 Real-time Quote.7.92%
S&P/CITIC 50 INDEX 0.44% 3716.67 Real-time Quote.7.89%
SILVERGATE CAPITAL CORPORATION -2.42% 14.11 Delayed Quote.-16.90%
WTI 0.36% 81.416 Delayed Quote.-0.46%
All news about APOLLO ENDOSURGERY, INC.
01/23Cowen Downgrades Apollo Endosurgery to Market Perform From Outperform, Adjusts Price Ta..
MT
01/05North American Morning Briefing: Futures Dip As a -2-
DJ
01/04Stifel Downgrades Apollo Endosurgery to Hold From Buy, Price Target is $10
MT
2022Apollo Endosurgery, Inc. : Unregistered Sale of Equity Securities (form 8-K)
AQ
2022Apollo Endosurgery : Merger Agreement - Form 8-K
PU
2022Apollo Endosurgery, Inc. : Other Events (form 8-K)
AQ
2022Apollo Endosurgery To Be Acquired By Boston Scientific
AQ
2022North American Morning Briefing: Stock Futures -2-
DJ
2022Lake Street Downgrades Apollo Endosurgery to Hold From Buy, Adjusts Price Target to $10..
MT
2022Apollo Endosurgery, Inc. : Entry into a Material Definitive Agreement, Financial Statement..
AQ
More news
Analyst Recommendations on APOLLO ENDOSURGERY, INC.
More recommendations
Financials (USD)
Sales 2022 75,4 M - -
Net income 2022 -39,2 M - -
Net Debt 2022 - - -
P/E ratio 2022 -10,2x
Yield 2022 -
Capitalization 468 M 468 M -
Capi. / Sales 2022 6,21x
Capi. / Sales 2023 5,25x
Nbr of Employees 202
Free-Float 92,2%
Chart APOLLO ENDOSURGERY, INC.
Duration : Period :
Apollo Endosurgery, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends APOLLO ENDOSURGERY, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 9,85 $
Average target price 11,00 $
Spread / Average Target 11,7%
EPS Revisions
Managers and Directors
Charles S. McKhann President, Chief Executive Officer & Director
Jeffrey G. Black Chief Financial Officer, Secretary & Treasurer
John R. Barr Chairman
Christopher J. Gostout Chief Medical Officer
Tiffanie Gilbreth Vice President-Clinical & Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
APOLLO ENDOSURGERY, INC.-1.20%468
NOVOCURE LIMITED22.92%9 462
PENUMBRA, INC.7.37%9 072
MASIMO CORPORATION13.27%8 749
SHOCKWAVE MEDICAL, INC.-10.91%6 887
GETINGE AB6.89%6 147